We also verified ADAMTS9‐AS1 expression levels in CRC clinical samples, and the Kaplan‐Meier analysis showed that low expression level of ADAMTS9‐AS1 correlated with significantly poorer prognosis than those with high expression levels. Here, ADAMTS9 is linked to colorectal carcinoma.